Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

418

Participants

Timeline

Start Date

January 27, 2014

Primary Completion Date

April 8, 2015

Study Completion Date

April 8, 2015

Conditions
Binge Eating Disorder
Interventions
DRUG

Lisdexamfetamine dimesylate

SDP489 30, 50, or 70mg capsule once per day (open-label and double-blind periods)

OTHER

Placebo

Placebo capsule once per day (double-blind period)

Trial Locations (53)

10117

Klinische Forschung Berlin-Mitte GmbH, Berlin

10629

EMOVIS GmbH - Klinische Forschung, Berlin

11214

Brooklyn Medical Institute, Brooklyn

18104

Lehigh Center for Clinical Research, Allentown

19055

Forschung Schwerin GmbH, Friedrichstrasse 1, Schwerin

26655

Studienzentrum Nordwest, Westerstede

27612

Wake Research Associates, LLC, Raleigh

28031

Hospital Universitario Infanta Leonor, Madrid

28822

Hospital del Henares, Madrid

29464

Coastal Carolina Research Center, Mt. Pleasant

29621

Radiant Research, Inc, Anderson

29650

Radiant Research, Inc, Greer

30159

Klinische Forschung Hannover-Mitte GmbH, Hanover

30342

NeuroTrials Research, Inc, Atlanta

32751

Florida Clinical Research Center, LLC, Maitland

32806

Clinical Neuroscience Solutions, Inc, Orlando

33143

Miami Research Associates, South Miami

33161

Scientific Clinical Research, Inc, North Miami

33319

Innovative Clinical Research, Inc, Lauderhill

33912

Gulfcoast Clinical Research Center, Fort Myers

34748

Compass Research LLC North Clinic, Leesburg

38119

Clinical Neuroscience Solution, Inc, Memphis

45040

Linder Center of Hope, Mason

45215

Patient Priority Clinical Sites, LLC, Cincinnati

45227

Community Research, Cincinnati

45417

Midwest Clinical Research Center, Dayton

46260

Goldpoint Clinical Research, Indianapolis

48307

Rochester Center for Behavioral Medicine, Rochester Hills

60048

Capstone Clinical Research, Libertyville

66206

Clinical Trials Technology, Inc, Prairie Village

67226

Cypress Medical Research Center, Wichita

70114

Louisiana Research Associates, Inc, New Orleans

75093

Research Across America, Plano

75231

FutureSearch Trials of Dallas, LP, Dallas

77081

Texas Center for Drug Development, Inc, Houston

78229

Radiant Research, Inc, San Antonio

78731

FutureSearch Clinical Trials, LP, Austin

87102

HBSA-Pacific Institute for Research & Evaluation, Albuquerque

97214

Oregon Center for Clinical Investigations, Inc (OCCI, Inc), Portland

97301

Oregon Center for Clinical Investigations, Inc (OCCI, Inc), Salem

98007

Northwest Clinical Research Center, Bellevue

98104

Summit Research Network (Seattle) LLC, Seattle

02478

McLean Hospital, Belmont

02131

Boston Clinical Trials, Boston

02472

Adams Clinical Trials, LLC, Watertown

02886

Omega Medical Research, Warwick

L5< 4N4

Anxiety and Mood Disorder Center, Mississauga

H9R 4S3

Manna Research, Pointe-Claire

01069

Klinische Forschung Dresden GmbH, Dresden

08025

Hospital de la Santa Creu I Sant Pau, Barcelona

211 52

Lakarmottagningen Ekdahl & Kronberg, Malmo

114 86

Sofiahemmet, Stockholm

118 50

Stockholm Center for Eating Disorders, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY